Procter & Gamble Health Share Price Today

Procter & Gamble Health FY26 Results: Net profit up 30%, sales rise 16%

Net profit rose 30% YoY while sales grew 16% in FY26. Productivity initiatives yielded ₹35 crore in cost savings. Fiscal year shifted to April-March cycle for better comparability. Shareholders approved director reappointments and final dividend.

Procter & Gamble Health files FY26 sustainability report with exchanges

Procter & Gamble Health Limited filed its FY26 sustainability report, revealing a turnover of ₹1,385 crore and net worth of ₹524 crore. Environmental metrics show reduced Scope 1 emissions to 190 metric tonnes and lower energy intensity. The company maintained zero landfill waste at its Goa plant and improved well-being spending to 0.50% of revenue.

Procter & Gamble Health Q1FY27 profit surges 45% on ₹318cr property sale gain

Procter & Gamble Health Limited reported a 45% surge in Q1FY27 net profit to ₹961.5 million, largely due to a ₹318 million exceptional gain from selling office premises. Revenue from operations rose 7.4% to ₹3,637.1 million, driven by strong pharmaceutical sales. However, core net profit before exceptional items fell 2.8% to ₹643.5 million, signaling that the bottom-line improvement is not reflective of ongoing operational trends.

P&G Health fixes Aug 27, 2026 as record date for AGM, dividend

Procter & Gamble Health Limited has announced August 27, 2026 as the record date for its 59th AGM and final dividend. The meeting is set for September 3, 2026, with dividend payment expected by September 27, 2026, pending shareholder approval.

P&G Health appoints Shine Matthew Sunny, reshuffles senior management

Procter & Gamble Health Limited announced a restructuring of its senior management team effective July 1, 2026, appointing Shine Matthew Sunny as the Marketing Strategy and Planning leader. Concurrently, Mr. Abhijit Roy, Mr. M. Padmakar Rao, and Mr. Nilesh Barbade were reassigned to new regional and functional roles to leverage their extensive experience in sales and trade.

P&G Health sets Rs 45 dividend, TDS exemption deadline August 12

Procter & Gamble Health Limited has recommended a final dividend of Rs 45 per equity share for FY 2025-26. The company outlined TDS rates for resident and non-resident shareholders, setting a deadline of August 12, 2026, for submitting exemption forms.